SAC Capital has just put out a new Schedule 13G disclosing ownership in 7,876,700 shares of ARIA as of April 17th. This gives SAC 4.9% ownership in ARIA and is an increase of 5,325,375 shares over their last reported position on 12/31/2011.
ARIAD Pharmaceutials is an oncology company focusing on the discovery, development, and commercialization of medicines for cancer patients.
SAC Capital is a Connecticut based hedge fund found by Steven Cohen in 1992.
|Reported via||Date||Name||Ticker||Shares||% of Portfolio|
|13F||2009-12-31||Ariad Pharmaceuticals Inc.||ARIA||76,892||0.00|
|13F||2010-09-30||Ariad Pharmaceuticals Inc.||ARIA||600||0.00|
|13F||2011-03-31||Ariad Pharmaceuticals Inc.||ARIA||18,285||0.00|
|13F||2011-06-30||Ariad Pharmaceuticals Inc.||ARIA||109,578||0.01|
|13F||2011-09-30||Ariad Pharmaceuticals Inc.||ARIA||176,796||0.01|
|13F||2011-12-31||Ariad Pharmaceuticals Inc.||ARIA||2,551,325||0.20|
|SC 13G||2012-04-27||Ariad Pharmaceuticals Inc.||ARIA||7,876,700||N/A|